CN115015533A - 一种氧化低密度脂蛋白测定试剂盒 - Google Patents
一种氧化低密度脂蛋白测定试剂盒 Download PDFInfo
- Publication number
- CN115015533A CN115015533A CN202210607675.7A CN202210607675A CN115015533A CN 115015533 A CN115015533 A CN 115015533A CN 202210607675 A CN202210607675 A CN 202210607675A CN 115015533 A CN115015533 A CN 115015533A
- Authority
- CN
- China
- Prior art keywords
- reagent
- density lipoprotein
- oxidized low
- alkyl glycoside
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010071584 oxidized low density lipoprotein Proteins 0.000 title claims abstract description 53
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 63
- 229930182470 glycoside Natural products 0.000 claims abstract description 33
- -1 alkyl glucoside Chemical class 0.000 claims abstract description 31
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000004816 latex Substances 0.000 claims abstract description 14
- 229920000126 latex Polymers 0.000 claims abstract description 14
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 10
- 239000004471 Glycine Substances 0.000 claims abstract description 9
- 239000007983 Tris buffer Substances 0.000 claims abstract description 9
- 239000007853 buffer solution Substances 0.000 claims abstract description 9
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 238000003149 assay kit Methods 0.000 claims description 7
- 150000002338 glycosides Chemical class 0.000 claims description 7
- 239000003755 preservative agent Substances 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 abstract description 8
- 229930182478 glucoside Natural products 0.000 abstract 1
- 238000001514 detection method Methods 0.000 description 16
- 238000012795 verification Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 210000001616 monocyte Anatomy 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- 101710095342 Apolipoprotein B Proteins 0.000 description 2
- 102100040202 Apolipoprotein B-100 Human genes 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000007817 turbidimetric assay Methods 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000004796 pathophysiological change Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
编号 | 下限值(U/mL) | 上限值(U/mL) | R<sup>2</sup> |
实施例1 | 0.125 | 35 | 0.9996 |
实施例2 | 0.25 | 35 | 0.9981 |
实施例3 | 0.25 | 35 | 0.9983 |
比较例1 | 0.5 | 35 | 0.9842 |
天数 | 0 | 2 | 4 | 6 | 8 | 10 |
实施例1 | 35.14 | 34.33 | 33.54 | 32.89 | 32.07 | 31.28 |
实施例2 | 35.16 | 34.05 | 33.19 | 31.88 | 30.57 | 29.42 |
实施例3 | 35.22 | 33.72 | 32.45 | 31.08 | 29.79 | 28.36 |
比较例1 | 35.37 | 33.07 | 31.08 | 28.95 | 26.37 | 24.31 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210607675.7A CN115015533B (zh) | 2022-05-31 | 2022-05-31 | 一种氧化低密度脂蛋白测定试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210607675.7A CN115015533B (zh) | 2022-05-31 | 2022-05-31 | 一种氧化低密度脂蛋白测定试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115015533A true CN115015533A (zh) | 2022-09-06 |
CN115015533B CN115015533B (zh) | 2024-06-25 |
Family
ID=83070437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210607675.7A Active CN115015533B (zh) | 2022-05-31 | 2022-05-31 | 一种氧化低密度脂蛋白测定试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115015533B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117192134A (zh) * | 2023-09-14 | 2023-12-08 | 宁波美康盛德生物科技有限公司 | 一种氧化型低密度脂蛋白的检测试剂盒、检测方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007149096A1 (en) * | 2006-06-23 | 2007-12-27 | Aegis Therapeutics, Inc. | Stabilizing alkylglycoside compositions and methods thereof |
CN103197084A (zh) * | 2013-03-28 | 2013-07-10 | 山东博科生物产业有限公司 | 一种稳定的糖化血清蛋白检测试剂及应用 |
CN104181308A (zh) * | 2014-08-22 | 2014-12-03 | 山东博科生物产业有限公司 | 一种稳定的肌钙蛋白i检测试剂 |
CN104597252A (zh) * | 2015-01-23 | 2015-05-06 | 浙江卓运生物科技有限公司 | 一种人血清氧化低密度脂蛋白的免疫比浊检测试剂盒 |
CN105911297A (zh) * | 2016-07-07 | 2016-08-31 | 宏葵生物(中国)有限公司 | 胶乳增强免疫比浊法检测心型脂肪酸结合蛋白的试剂盒 |
JP2020052012A (ja) * | 2018-09-28 | 2020-04-02 | 株式会社Lsiメディエンス | 不溶性担体を使用する免疫学的測定試薬 |
-
2022
- 2022-05-31 CN CN202210607675.7A patent/CN115015533B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007149096A1 (en) * | 2006-06-23 | 2007-12-27 | Aegis Therapeutics, Inc. | Stabilizing alkylglycoside compositions and methods thereof |
CN103197084A (zh) * | 2013-03-28 | 2013-07-10 | 山东博科生物产业有限公司 | 一种稳定的糖化血清蛋白检测试剂及应用 |
CN104181308A (zh) * | 2014-08-22 | 2014-12-03 | 山东博科生物产业有限公司 | 一种稳定的肌钙蛋白i检测试剂 |
CN104597252A (zh) * | 2015-01-23 | 2015-05-06 | 浙江卓运生物科技有限公司 | 一种人血清氧化低密度脂蛋白的免疫比浊检测试剂盒 |
CN105911297A (zh) * | 2016-07-07 | 2016-08-31 | 宏葵生物(中国)有限公司 | 胶乳增强免疫比浊法检测心型脂肪酸结合蛋白的试剂盒 |
JP2020052012A (ja) * | 2018-09-28 | 2020-04-02 | 株式会社Lsiメディエンス | 不溶性担体を使用する免疫学的測定試薬 |
Non-Patent Citations (1)
Title |
---|
康 鹏,王 侃,方灵丹: "烷基糖苷的合成及应用特点", 中国洗涤用品工业, no. 8, pages 406 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117192134A (zh) * | 2023-09-14 | 2023-12-08 | 宁波美康盛德生物科技有限公司 | 一种氧化型低密度脂蛋白的检测试剂盒、检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115015533B (zh) | 2024-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4275053A (en) | Blood cell typing and compatibility test procedure | |
JP3645023B2 (ja) | 試料分析方法、検量線の作成方法及びそれを用いる分析装置 | |
CA1195925A (en) | Method for assaying antigen-antibody reactions and reagent therefor | |
CN107942069A (zh) | 一种ngal胶乳免疫比浊法检测试剂盒及其制备方法 | |
EP2287609A1 (en) | Method for production of insoluble carrier particle, insoluble carrier particle, measurement reagent, sample analysis tool, and immunology turbidimetric method | |
US7074621B2 (en) | Surface plasmon resonance biosensor for measurement of anti-glycolipid antibody levels in neuropathy | |
JP3451091B2 (ja) | 全血試料中に存在する分析対象成分の定量に用いる分析用キュベット、定量方法及び診断検査キット | |
US4328183A (en) | Blood cell typing and compatibility test procedure | |
CN115015533A (zh) | 一种氧化低密度脂蛋白测定试剂盒 | |
CN106370860A (zh) | 血清免疫球蛋白e胶体金层析定量检测试剂盒及试纸条 | |
CN105467131A (zh) | 可以同时检测尿液和血清样本中α1-微球蛋白的试剂盒 | |
CN102128924A (zh) | 乳胶增强免疫比浊法测定尿液转铁蛋白试剂盒及其制备方法 | |
CN106546729B (zh) | 一种去除干式免疫荧光定量法检测中血清基质效应的新工艺方法 | |
JP2553852B2 (ja) | サンプル中の生物学的物質の免疫学的測定法 | |
CN117848778A (zh) | 用于制备泪液稀释液的方法 | |
EP0684477A2 (en) | Calibrator matrix | |
Barron et al. | The use of polyethylene glycol (PEG) to enhance the adsorption of autoantibodies | |
Laurell | The use of electroimmunoassay for determining specific proteins as a supplement to agarose gel electrophoresis. | |
Richardson et al. | Antigen and antibody attachment in ELISA for Aspergillus fumigatus IgG antibodies | |
JP4524446B2 (ja) | 糖脂質抗原の活性化剤及び活性化方法、並びに試料中の抗糖脂質抗体の測定方法及び測定試薬キット | |
CA1089359A (en) | Blood cell typing and compatibility test by solid phase immunoadsorbtion | |
JP4556605B2 (ja) | 標的物質の測定方法および測定試薬 | |
RU2180117C1 (ru) | Способ оценки сенсибилизации к химическим соединениям | |
JP3290520B2 (ja) | 抗リン脂質抗体測定法 | |
Penney et al. | Polycarbonate membranes: a novel surface for solid-phase determinations with utility in field format serological assays |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Yi Jianfeng Inventor after: Ma Qingwei Inventor after: Nie Zongxiu Inventor after: Cai Qihao Inventor after: Qian Wei Inventor after: Zeng Yaolong Inventor after: Wang Zhiyi Inventor before: Yi Jianfeng Inventor before: Ma Qingwei Inventor before: Yan Zongxiu Inventor before: Cai Qihao Inventor before: Qian Wei Inventor before: Zeng Yaolong Inventor before: Wang Zhiyi |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |